Kozauer N, Katz R. Regulatory innovation and drug development for early-stage Alzheimer's disease. N Engl J Med. 2013 Mar 28;368(13):1169-71. Epub 2013 Mar 13 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Gantenerumab, Aducanumab: Bobbing Up and Down While Navigating Currents of Trial Design
  2. Outcomes, Outcomes: Cognition is Crux of New Alzheimer’s Trials
  3. Truly New to Déjà Vu: Investigational Therapy News at CTAD

Research Timeline Event

  1. FDA issues guidance for therapy development in early AD